Evaluation of inflammatory substances in the blood of patients with recurrent glioblastoma in treatment with inhalation of perillyl alcohol associated with reduced carbohydrate diet and supplementation with omega 3
Not Applicable
- Conditions
- GlioblastomaC04.557.465.625.600.380.080.335
- Registration Number
- RBR-3byz2c
- Lead Sponsor
- Hospital Universitário Antônio Pedro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adults with glioblastoma; submitted to surgical procedure with the partial withdrawal of the tumor; who presented recurrences and are under chemotherapeutic treatment.
Exclusion Criteria
Participants who initiate immunotherapeutic treatment; or develop autoimmune; hepatic or renal disease; or discontinue the ketogenic diet; perillyl alcohol inhalation or supplement will be excluded.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival free of progression of participants, monitored by magnetic resonance imaging after 1 year of study.
- Secondary Outcome Measures
Name Time Method The combined treatment is expected to stabilize tumor growth, which will be checked at baseline and after 2 months of study.